Skip to main content

Advertisement

Log in

Multiple cranial neuropathy and intracranial hypertension associated with all-trans retinoic acid treatment in a young adult patient with acute promyelocytic leukemia

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

All-trans retinoic acid (ATRA) induces complete remission in 64–100 % of patients with acute promyelocytic leukemia (APL), and is considered to be a safe agent. Pseudotumor cerebri is a neurological side effect of ATRA reported in pediatric patients, and which is characterized by raised cerebrospinal fluid pressure in the absence of any intracranial pathology or secondary causes of intracranial hypertension. Involvement of cranial nerves other than II and VI is very uncommon in idiopathic intracranial hypertension (IIH); peripheral facial nerve palsy is exceptional and has rarely been described in the context of treatment with ATRA. We describe the case of a 15-year-old female patient with APL who developed an IIH and involvement of cranial nerves (bilateral papilledema, left facial and right sixth nerves) after receiving induction therapy including ATRA. Viral infections and other causes of secondary cranial nerve lesions were excluded. Symptoms completely subsided with the temporary withdrawal of ATRA and did not recur after reintroducing the drug. To date, the patient has managed to receive the treatment as per protocol. In conclusion, we report an atypical presentation of IIH that merits consideration, especially with respect to young patients with APL receiving ATRA; our most important observation is that the drug could be safely reintroduced once the symptoms had resolved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Gillis JC, Goa KL. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia. Drugs. 1995;50(5):897–923.

    Article  PubMed  CAS  Google Scholar 

  2. VESANOID® product monograph. Hoffmann La Roche Ltd: Mississauga, Ontario. 1999.

  3. BCCA Cancer Drug Manual©. 2001.

  4. Testi AM, Biondi A. Lo Coco F, Moleti ML, Giona F, Vignetti M, et al. GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106(2):447–53.

    Article  PubMed  CAS  Google Scholar 

  5. Visani G, Manfroi S, Tosi P, Martinelli G. All-trans-retinoic acid and pseudotumor cerebri. Leuk Lymphoma. 1996;23(5–6):437–42.

    Article  PubMed  CAS  Google Scholar 

  6. Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand. 2010;121(2):71–82.

    Article  PubMed  CAS  Google Scholar 

  7. Capobianco DJ, Brazis PW, Cheshire WP. Idiopatic intracranial hypertension and seventh nerve palsy. Headache. 1997;37(5):286–8.

    Article  PubMed  CAS  Google Scholar 

  8. Han JY, Kim KE, Kim KH, Park JI, Kim JS. Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH. Leuk Res. 2007;31(2):239–43.

    Article  PubMed  CAS  Google Scholar 

  9. Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, et al. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010;115(25):5137–46.

    Article  PubMed  CAS  Google Scholar 

  10. Montesinos P, Vellenga E, Holowiecka A, Rayon C, Milone G, de la Serna J, et al. Incidence, outcome and risk factors of pseudotumor cerebri after all-trans retinoic acid and anthracycline-based chemotherapy in patients with acute promyelocytic leukemia. Blood (ASH Annual Meeting Abstract) 2008; 112: Abstract 2992.

  11. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113:1875–91.

    Article  PubMed  CAS  Google Scholar 

  12. Sacchi S, Russo D, Avvisati G, Dastoli G, Lazzarino M, Pelicci PG, et al. All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi). Haematologica. 1997;82(1):106–21.

    PubMed  CAS  Google Scholar 

  13. Mahmoud HH, Hurwitz CA, Roberts WM, Santana VM, Ribeiro RC, Krance RA. Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet. 1993;342(8884):1394–5.

    Article  PubMed  CAS  Google Scholar 

  14. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492–5.

    Article  PubMed  Google Scholar 

  15. Naderi S, Nukala S, Marruenda F, Kudarvalli P, Koduri PR. Pseudotumour cerebri in acute promyelocytic leukemia: improvement despite continued ATRA therapy. Ann Hematol. 1999;78(7):333–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Labrador.

About this article

Cite this article

Labrador, J., Puig, N., Ortín, A. et al. Multiple cranial neuropathy and intracranial hypertension associated with all-trans retinoic acid treatment in a young adult patient with acute promyelocytic leukemia. Int J Hematol 96, 383–385 (2012). https://doi.org/10.1007/s12185-012-1134-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1134-6

Keywords

Navigation